Salvage therapy and formulation of highly active antiretroviral therapy

被引：0
|
作者：
Fessel, WJ [1 ]
Follansbee, SE [1 ]
Young, TP [1 ]
机构：
[1] Permanente Med Grp Inc, San Francisco, CA USA
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [31] Exploring the benefits and limits of highly active antiretroviral therapy
    D'Aquila, R
    Walker, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17): : 1668 - 1669
  • [32] Highly active antiretroviral therapy improves neurocognitive functioning
    Robertson, KR
    Robertson, WT
    Ford, S
    Watson, D
    Fiscus, S
    Harp, AG
    Hall, CD
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) : 562 - 566
  • [33] Lipodystrophy and metabolic complications of highly active antiretroviral therapy
    Parakh, Ankit
    Dubey, Anand Prakash
    Kumar, Ajay
    Maheshwari, Anshu
    INDIAN JOURNAL OF PEDIATRICS, 2009, 76 (10): : 1017 - 1021
  • [34] Immune reconstitution with highly active antiretroviral therapy.
    Autran, B
    Carcelain, C
    Renaud, M
    Li, TS
    Gorochov, G
    Tubiana, R
    Calvez, V
    Agut, H
    Leibowitch, J
    Katlama, C
    Debré, P
    AIDS, 1998, 12 : S2 - S2
  • [35] Maintaining infants and children on highly active antiretroviral therapy
    Rabie, Helena
    Marais, Ben J.
    Cotton, Mark F.
    SOUTH AFRICAN FAMILY PRACTICE, 2006, 48 (08) : 55 - 60
  • [36] Lipodystrophy and metabolic complications of highly active antiretroviral therapy
    Ankit Parakh
    Anand Prakash Dubey
    Ajay Kumar
    Anshu Maheshwari
    The Indian Journal of Pediatrics, 2009, 76 : 1017 - 1021
  • [37] Determining the relative efficacy of highly active antiretroviral therapy
    Louie, M
    Hogan, C
    Di Mascio, M
    Hurley, A
    Simon, V
    Rooney, J
    Ruiz, N
    Brun, S
    Sun, E
    Perelson, AS
    Ho, DD
    Markowitz, M
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (06): : 896 - 900
  • [38] AIDS malignancies in the era of highly active antiretroviral therapy
    Gates, AE
    Kaplan, LD
    ONCOLOGY-NEW YORK, 2002, 16 (05): : 657 - 665
  • [39] Opportunistic infections and highly active antiretroviral therapy (HAART)
    Gatell, JM
    MEDICINA CLINICA, 2001, 116 (02): : 56 - 57
  • [40] Highly active antiretroviral therapy and beta-chemokines
    Brichacek, B
    Bukrinsky, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (02): : 169 - 171
12345